KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,036 | +14.5% | 1,004 | 0.0% | 0.00% | – |
| Q1 2023 | $7,891 | +16.3% | 1,004 | 0.0% | 0.00% | – |
| Q4 2022 | $6,787 | -51.5% | 1,004 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | -94.3% | 1,004 | -94.6% | 0.00% | – |
| Q4 2021 | $247,000 | -24.2% | 18,705 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $326,000 | -27.2% | 18,705 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $448,000 | -6.7% | 18,705 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $480,000 | +12.9% | 18,705 | -16.8% | 0.00% | 0.0% |
| Q4 2020 | $425,000 | -72.1% | 22,486 | -81.4% | 0.00% | -66.7% |
| Q3 2020 | $1,521,000 | – | 120,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |